Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FoodMarble is a digital health company specializing in digestive health through portable breath analysis technology. The company's flagship products, AIRE and AIRE 2, allow users to measure hydrogen and methane levels in their breath to track how their bodies digest specific foods in real-time. By combining hardware with a mobile application, FoodMarble helps individuals with Irritable Bowel Syndrome (IBS) and Small Intestinal Bacterial Overgrowth (SIBO) identify trigger foods and manage their symptoms. The platform also offers clinical tools for healthcare professionals to monitor patients remotely and conduct breath tests outside of a hospital setting. Their technology aims to provide a personalized approach to gut health management through data-driven insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FoodMarble.